Founded with a mission to combat opioid abuse, OpiAID focuses on developing advanced wearable technology to aid in the treatment and prevention of opioid overdoses. The company's core vision is to enhance patient care through data-driven insights derived from their AI-powered Recovery Intelligence Platform. OpiAID's primary product is an AI-enabled wearable device designed to detect biological indicators of overdose, providing timely intervention and support for individuals struggling with opioid use disorder.
Notable figures affiliated with OpiAID include experts in healthcare technology and AI, although specific names are not provided. The company has attracted attention from investors interested in innovative health tech solutions. Key achievements include the successful development and deployment of their wearable technology, which has shown promise in improving treatment outcomes for opioid use disorder. Overall, OpiAID is making a significant impact by leveraging advanced technology to address a critical public health issue.
